HPS Pharmacies wish to give notice that Pfizer is experiencing a supply interruption for DBL™ Glyceryl Trinitrate ampoules as follows:
DBL™ Glyceryl Trinitrate Concentrate Injection
Glyceryl trinitrate 50mg/10mL
This supply interruption is due to an unexpected transit delay. There are no safety concerns with this product. Normal supplies are expected to resume by early July 2018.
HPS Pharmacies are currently able to source a limited supply of this product for the benefit of our clients. However, as Pfizer is the sole supplier of glyceryl trinitrate ampoules in Australia, it is recommended that available stock be reserved for situations where there is no therapeutic alternative.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on 1800 629 921.